Authors:
BRUZZI P
DOGLIOTTI L
NALDONI C
BUCCHI L
COSTANTINI M
CICOGNANI A
TORTA M
BUZZI GF
ANGELI A
Citation: P. Bruzzi et al., COHORT STUDY OF ASSOCIATION OF RISK OF BREAST-CANCER WITH CYST TYPE IN WOMEN WITH GROSS CYSTIC-DISEASE OF THE BREAST, BMJ. British medical journal, 314(7085), 1997, pp. 925-928
Authors:
BERRUTI A
SPERONE P
FASOLIS G
TORTA M
FONTANA D
DOGLIOTTI L
ANGELI A
Citation: A. Berruti et al., PAMIDRONATE ADMINISTRATION IMPROVES THE SECONDARY HYPERPARATHYROIDISMDUE TO BONE-HUNGER-SYNDROME IN A PATIENT WITH OSTEOBLASTIC METASTASESFROM PROSTATE-CANCER, The Prostate, 33(4), 1997, pp. 252-255
Authors:
PIOVESAN A
BERRUTI A
TORTA M
CANNONE R
SPERONE P
PANERO A
GORZEGNO G
TERMINE A
DOGLIOTTI L
ANGELI A
Citation: A. Piovesan et al., COMPARISON OF ASSAY OF TOTAL AND BONE-SPECIFIC ALKALINE-PHOSPHATASE IN THE ASSESSMENT OF OSTEOBLAST ACTIVITY IN PATIENTS WITH METASTATIC BONE-DISEASE, Calcified tissue international, 61(5), 1997, pp. 362-369
Authors:
TAMPELLINI M
BERRUTI A
GERBINO A
BUNIVA T
TORTA M
GORZEGNO G
FAGGIUOLO R
CANNONE R
FARRIS A
DESTEFANIS M
MORO G
DELTETTO F
DOGLIOTTI L
Citation: M. Tampellini et al., RELATIONSHIP BETWEEN CA-15-3 SERUM LEVELS AND DISEASE EXTENT IN PREDICTING OVERALL SURVIVAL OF BREAST-CANCER PATIENTS WITH NEWLY-DIAGNOSED METASTATIC DISEASE, British Journal of Cancer, 75(5), 1997, pp. 698-702
Authors:
BERRUTI A
TORTA M
PIOVESAN A
SPERONE P
DOGLIOTTI L
ANGELI A
Citation: A. Berruti et al., SERUM AND URINARY PROFILE OF BONE TURN-OVER MARKERS IN A PATIENT WITHTAMOXIFEN-INDUCED HYPERCALCEMIA SUBMITTED TO PAMIDRONATE THERAPY, Breast, 5(4), 1996, pp. 274-276
Authors:
BERRUTI A
PIOVESAN A
TORTA M
RAUCCI CA
GORZEGNO G
PACCOTTI P
DOGLIOTTI L
ANGELI A
Citation: A. Berruti et al., BIOCHEMICAL EVALUATION OF BONE TURNOVER IN CANCER-PATIENTS WITH BONE METASTASES - RELATIONSHIP WITH RADIOGRAPH APPEARANCES, British Journal of Cancer, 73(12), 1996, pp. 1581-1587
Authors:
TAMPELLINI M
BERRUTI A
GERBINO A
BUNIVA T
TORTA M
FAGGIUOLO R
GORZEGNO G
DOGLIOTTI L
Citation: M. Tampellini et al., PROGNOSTIC VALUE OF CA-15-3 IN ADVANCED BREAST-CANCER (BC) PATIENTS -RELATIONSHIP WITH THE DISEASE EXTENT (DE), European journal of cancer, 31A, 1995, pp. 681-681
Authors:
BUCCHI L
COSTANTINI M
BUZZI G
BRAVETTI P
CICOGNANI A
TORTA M
NALDONI C
DOGLIOTTI L
BRUZZI P
Citation: L. Bucchi et al., WOLFES MAMMOGRAPHIC PATTERNS IN WOMEN WITH GROSS CYSTIC-DISEASE OF THE BREAST, Journal of clinical epidemiology, 48(7), 1995, pp. 969-976
Authors:
TERZOLO M
PIOVESAN A
ALI A
CODEGONE A
PIA A
REIMONDO G
TORTA M
PACCOTTI P
BORRETTA G
ANGELI A
Citation: M. Terzolo et al., CIRCADIAN PROFILE OF SERUM MELATONIN IN PATIENTS WITH CUSHINGS-SYNDROME OR ACROMEGALY, Journal of endocrinological investigation, 18(1), 1995, pp. 17-24
Authors:
BERRUTI A
TORTA M
PIOVESAN A
RAUCCI CA
ORLANDI F
PANERO A
DOGLIOTTI L
ANGELI A
Citation: A. Berruti et al., BIOCHEMICAL PICTURE OF BONE METABOLISM IN BREAST-CANCER PATIENTS WITHBONE METASTASES, Anticancer research, 15(6B), 1995, pp. 2871-2875
Authors:
ANGELI A
DOGLIOTTI L
NALDONI C
ORLANDI F
PULIGHEDDU B
CARACI P
BUCCHI L
TORTA M
BRUZZI P
Citation: A. Angeli et al., STEROID BIOCHEMISTRY AND CATEGORIZATION OF BREAST CYST FLUID - RELATION TO BREAST-CANCER RISK, Journal of steroid biochemistry and molecular biology, 49(4-6), 1994, pp. 333-339
Authors:
BERRUTI A
TAMPELLINI M
TORTA M
BUNIVA T
GORZEGNO G
DOGLIOTTI L
Citation: A. Berruti et al., PROGNOSTIC VALUE IN PREDICTING OVERALL SURVIVAL OF 2 MUCINOUS MARKERS- CA-15-3 AND CA-125 IN BREAST-CANCER PATIENTS AT FIRST RELAPSE OF DISEASE, European journal of cancer, 30A(14), 1994, pp. 2082-2084
Authors:
NALDONI C
COSTANTINI M
DOGLIOTTI L
BRUZZI P
BUCCHI L
BUZZI G
TORTA M
ANGELI A
Citation: C. Naldoni et al., ASSOCIATION OF CYST TYPE WITH RISK-FACTORS FOR BREAST-CANCER AND RELAPSE RATE IN WOMEN WITH GROSS CYSTIC-DISEASE OF THE BREAST, Cancer research, 52(7), 1992, pp. 1791-1795